Oncovance
Trademark details
Oncovance® is a registered trademark used for Pharmaceuticals, Namely, Pharmaceutical Preparations and Reagents Used For Cancer Diagnosis and Treatment Computer Software For Use In the Field of Cancer Research, Diagnosis and Treatment, Namely, Computer Medical Software For Diagnosis, Prognosis and Maintenance of Treatment To Cancer Patients Medical and Scientific Research Services In the Field of Cancer Treatment and Diagnosis and owned by Oncovance Technologies, Inc.. Full trade mark registration details, registered images and more information below.
| Goods and/or Services: | Pharmaceuticals, Namely, Pharmaceutical Preparations and Reagents Used For Cancer Diagnosis and Treatment Computer Software For Use In the Field of Cancer Research, Diagnosis and Treatment, Namely, Computer Medical Software For Diagnosis, Prognosis and Maintenance of Treatment To Cancer Patients Medical and Scientific Research Services In the Field of Cancer Treatment and Diagnosis Design, Consulting and Development of Computer Software In the Field of Cancer Treatment, Scientific and Medical Research and Diagnosis Providing Health Care Services, Namely, Treating Cancer Patients |
| Serial Number: | 78329314 |
| Filing Date: | Nov 18, 2003 |
|
Last Applicant(s)/ Owner(s) of Record | Oncovance Technologies, Inc.1709 Dryden Road Suite 901 |
| Related Products: | Pharmaceuticals, Electrical and Scientific Apparatus, Miscellaneous Services; Scientific and technological services, and research and design relating thereto; Industrial analysis and research services; Design and development of computer hardware and software; Legal services, Medical services; Veterinary services; Hygienic and beauty care for humans or animals |
Web Sites
powered by 
Total : 314 View more »
Oncovance Technologies, Inc.: Private Company Information ...
Oncovance Technologies, Inc. company research & investing information. Find executives and the latest company news.
BCM Technologies : Past Portfolio
Oncovance Technologies: PrimaCIS Health information Technology, Inc. PrimaCIS was acquired by MedicaLogic ...
UltraSensitive PSA Example
12/5/2007 ... Topic 003.1 - Example State Diagram – Oncovance 40 PC Disease States
cindy sheridan profiles | LinkedIn
CEO at Oncovance Technologies, Inc., Adjunct Professor at University of Texas at Austin, Associate Professor at St. Edward's University, CEO at IBT Technologies, Inc ...
Explore Related Topics:
Related Products:
